Free tool
FAERS Monitor: Humatrope
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming BLA 019640 or its brand name (Humatrope, Somatropin). Reports on generic versions are filed under their own applications.
Reports
11,846
Serious
6,001
51% of reports
Hospitalization
2,327
Death reported
475
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- incorrect dose administered1,016
- injection site pain643
- off label use511
- headache481
- drug dose omission431
- fatigue424
- underdose407
- device leakage342
- malaise325
- wrong technique in product usage process260
- drug ineffective244
- drug dose omission by device222
- nausea221
- injection site bruising219
- pyrexia209
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 148 |
| 2005 | 161 |
| 2006 | 156 |
| 2007 | 212 |
| 2008 | 197 |
| 2009 | 350 |
| 2010 | 277 |
| 2011 | 327 |
| 2012 | 388 |
| 2013 | 197 |
| 2014 | 272 |
| 2015 | 2,473 |
| 2016 | 575 |
| 2017 | 531 |
| 2018 | 622 |
| 2019 | 782 |
| 2020 | 710 |
| 2021 | 440 |
| 2022 | 538 |
| 2023 | 854 |
| 2024 | 798 |
| 2025 | 505 |
| 2026 | 333 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,042,313 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| device leakageSignal | 342 | 14.1 | 12.7 | 4,128 |
| underdoseSignal | 407 | 9.9 | 9.0 | 3,260 |
| incorrect dose administeredSignal | 1,016 | 7.9 | 7.5 | 6,190 |
| drug dose omission by deviceSignal | 222 | 5.0 | 4.4 | 717 |
| injection site bruisingSignal | 219 | 4.9 | 4.3 | 673 |
| drug dose omissionSignal | 431 | 4.6 | 4.2 | 1,233 |
| injection site painSignal | 643 | 3.7 | 3.5 | 1,297 |
| wrong technique in product usage processSignal | 260 | 2.3 | 2.0 | 187 |
| headache | 481 | 1.4 | 1.2 | 47 |
| malaise | 325 | 1.3 | 1.2 | 25 |
| pyrexia | 209 | 1.1 | 0.9 | 1 |
| off label use | 511 | 1.0 | 1.0 | 1 |
| fatigue | 424 | 1.0 | 0.9 | 0 |
| nausea | 221 | 0.5 | 0.4 | 117 |
| drug ineffective | 244 | 0.3 | 0.3 | 356 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.